Matches in Wikidata for { <http://www.wikidata.org/entity/Q100745837> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q100745837 description "2020 ވަނަ އަހަރުގެ އޮކްޓޯބަރުމަހުގެ 17ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ލިޔުމެއް" @default.
- Q100745837 description "artículu científicu espublizáu n'ochobre de 2020" @default.
- Q100745837 description "scientific article published on 17 October 2020" @default.
- Q100745837 description "wetenschappelijk artikel" @default.
- Q100745837 description "наукова стаття, опублікована 17 жовтня 2020" @default.
- Q100745837 name "A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders" @default.
- Q100745837 name "A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders" @default.
- Q100745837 name "A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders" @default.
- Q100745837 type Item @default.
- Q100745837 label "A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders" @default.
- Q100745837 label "A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders" @default.
- Q100745837 label "A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders" @default.
- Q100745837 prefLabel "A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders" @default.
- Q100745837 prefLabel "A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders" @default.
- Q100745837 prefLabel "A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders" @default.
- Q100745837 P1433 Q100745837-4D3D800E-44E3-4547-BDE0-1A3614CA5B7F @default.
- Q100745837 P1476 Q100745837-7746D22D-A3FE-4AE0-962C-75965B8A6CEE @default.
- Q100745837 P2093 Q100745837-0C622227-940A-48A2-8E4F-341D49126644 @default.
- Q100745837 P2093 Q100745837-18DC19D2-FB69-4AD7-BD88-996565CC32B7 @default.
- Q100745837 P2093 Q100745837-24D2BC34-A184-42D0-8B8B-887A85F0A82B @default.
- Q100745837 P2093 Q100745837-8AD5625F-25E5-4931-A4C8-C53FEC720687 @default.
- Q100745837 P2093 Q100745837-B5814C33-38A7-4655-B5CE-A81B2A88B5E7 @default.
- Q100745837 P2093 Q100745837-D9A25E28-485E-4900-932D-AE19610D294D @default.
- Q100745837 P2093 Q100745837-E2E93EBE-225B-4EB7-A64B-F597ACD73315 @default.
- Q100745837 P304 Q100745837-A0D05B38-82D7-4D12-A5C1-EC8B0C68C047 @default.
- Q100745837 P31 Q100745837-A9EF24C8-82D6-4595-8BC2-38367348A3C9 @default.
- Q100745837 P356 Q100745837-14D6EC51-0B5D-4DA3-A781-E69F6ECB2FE9 @default.
- Q100745837 P478 Q100745837-DD55BF5C-2F79-4BC9-AAAC-8FA7F48FB7D7 @default.
- Q100745837 P577 Q100745837-68A65884-7319-4C49-9CD2-A9B0E19F4A7B @default.
- Q100745837 P698 Q100745837-6679109A-B83B-48A0-A161-25DF9A50B39F @default.
- Q100745837 P921 Q100745837-43626A29-34E6-41CA-995F-1753932D39F4 @default.
- Q100745837 P356 J.BIOPHA.2020.110890 @default.
- Q100745837 P698 33080465 @default.
- Q100745837 P1433 Q15759648 @default.
- Q100745837 P1476 "A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders" @default.
- Q100745837 P2093 "Ari Zimran" @default.
- Q100745837 P2093 "David Arkadir" @default.
- Q100745837 P2093 "Devorah Rotnemer-Golinkin" @default.
- Q100745837 P2093 "Lidya Zolotarovya" @default.
- Q100745837 P2093 "Tawfik Khoury" @default.
- Q100745837 P2093 "Yaron Ilan" @default.
- Q100745837 P2093 "Yuval Ishay" @default.
- Q100745837 P304 "110890" @default.
- Q100745837 P31 Q13442814 @default.
- Q100745837 P356 "10.1016/J.BIOPHA.2020.110890" @default.
- Q100745837 P478 "132" @default.
- Q100745837 P577 "2020-10-17T00:00:00Z" @default.
- Q100745837 P698 "33080465" @default.
- Q100745837 P921 Q157661 @default.